Wu XR - Search Results

1

Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.

He F, Melamed J, Tang MS, Huang C, Wu XR. He F, et al. Among authors: wu xr. Cancer Res. 2015 May 15;75(10):2017-28. doi: 10.1158/0008-5472.CAN-14-3067. Epub 2015 Mar 20. Cancer Res. 2015. PMID: 25795707 Free PMC article.

2

Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.

He F, Mo L, Zheng XY, Hu C, Lepor H, Lee EY, Sun TT, Wu XR. He F, et al. Among authors: wu xr. Cancer Res. 2009 Dec 15;69(24):9413-21. doi: 10.1158/0008-5472.CAN-09-2158. Cancer Res. 2009. PMID: 19951992 Free PMC article.

3

FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma.

Zhou H, He F, Mendelsohn CL, Tang MS, Huang C, Wu XR. Zhou H, et al. Among authors: wu xr. Sci Rep. 2016 May 9;6:25596. doi: 10.1038/srep25596. Sci Rep. 2016. PMID: 27157475 Free PMC article.

4

PKM2 Is Essential for Bladder Cancer Growth and Maintenance.

Xia Y, Wang X, Liu Y, Shapiro E, Lepor H, Tang MS, Sun TT, Wu XR. Xia Y, et al. Among authors: wu xr. Cancer Res. 2022 Feb 15;82(4):571-585. doi: 10.1158/0008-5472.CAN-21-0403. Cancer Res. 2022. PMID: 34903602 Free PMC article.

5

Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer.

He F, Zhang F, Liao Y, Tang MS, Wu XR. He F, et al. Among authors: wu xr. Cancer Lett. 2022 Dec 1;550:215924. doi: 10.1016/j.canlet.2022.215924. Epub 2022 Oct 3. Cancer Lett. 2022. PMID: 36195293 Free PMC article.

6

Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.

Zhou H, Huang HY, Shapiro E, Lepor H, Huang WC, Mohammadi M, Mohr I, Tang MS, Huang C, Wu XR. Zhou H, et al. Among authors: wu xr. Carcinogenesis. 2012 Apr;33(4):770-80. doi: 10.1093/carcin/bgs025. Epub 2012 Jan 27. Carcinogenesis. 2012. PMID: 22287562 Free PMC article.

7

Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis.

Zhou H, Wang X, Mo L, Liu Y, He F, Zhang F, Huang KH, Wu XR. Zhou H, et al. Among authors: wu xr. Oncotarget. 2016 Apr 26;7(17):23947-60. doi: 10.18632/oncotarget.8114. Oncotarget. 2016. PMID: 26992222 Free PMC article.

8

XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells.

Jin H, Xu J, Guo X, Huang H, Li J, Peng M, Zhu J, Tian Z, Wu XR, Tang MS, Huang C. Jin H, et al. Among authors: wu xr. Oncotarget. 2016 Aug 30;7(35):56540-56557. doi: 10.18632/oncotarget.10645. Oncotarget. 2016. PMID: 27447744 Free PMC article.

9

Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis.

Xia Y, Liu Y, Yang C, Simeone DM, Sun TT, DeGraff DJ, Tang MS, Zhang Y, Wu XR. Xia Y, et al. Among authors: wu xr. Nat Commun. 2021 Apr 6;12(1):2047. doi: 10.1038/s41467-021-22327-5. Nat Commun. 2021. PMID: 33824349 Free PMC article.

10

XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability.

Yu Y, Jin H, Xu J, Gu J, Li X, Xie Q, Huang H, Li J, Tian Z, Jiang G, Chen C, He F, Wu XR, Huang C. Yu Y, et al. Among authors: wu xr. Int J Cancer. 2018 May 15;142(10):2040-2055. doi: 10.1002/ijc.31223. Epub 2017 Dec 28. Int J Cancer. 2018. PMID: 29250796 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters